119 related articles for article (PubMed ID: 27391901)
1. Combined first-trimester Down syndrome screening in HIV-infected women.
Chougrani I; Muller F; Marcelin L; Tsatsaris V; Abric J; Luton D; Guibourdenche J; Azria E
Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():274-8. PubMed ID: 27391901
[TBL] [Abstract][Full Text] [Related]
2. Maternal biochemical serum screening for Down syndrome in pregnancy with human immunodeficiency virus infection.
Le Meaux JP; Tsatsaris V; Schmitz T; Fulla Y; Launay O; Goffinet F; Azria E
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):223-30. PubMed ID: 18669715
[TBL] [Abstract][Full Text] [Related]
3. First-trimester markers of aneuploidy in women positive for HIV.
Savvidou MD; Samuel I; Syngelaki A; Poulton M; Nicolaides KH
BJOG; 2011 Jun; 118(7):844-8. PubMed ID: 21062401
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
6. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
7. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K
Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
[TBL] [Abstract][Full Text] [Related]
8. First and second trimester markers of fetal aneuploidy in pregnant women with HIV infection.
Spencer K
Fetal Diagn Ther; 2011; 29(2):135-8. PubMed ID: 20714121
[TBL] [Abstract][Full Text] [Related]
9. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation.
Wright D; Spencer K; Kagan K K; Tørring N; Petersen OB; Christou A; Kallikas J; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Oct; 36(4):404-11. PubMed ID: 20658511
[TBL] [Abstract][Full Text] [Related]
10. Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study.
Brossard P; Boulvain M; Coll O; Barlow P; Aebi-Popp K; Bischof P; Martinez de Tejada B; ;
AIDS; 2008 Oct; 22(15):2013-7. PubMed ID: 18784463
[TBL] [Abstract][Full Text] [Related]
11. First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free-β human chorionic gonadotrophin, placental growth factor, and α-fetoprotein.
Huang T; Dennis A; Meschino WS; Rashid S; Mak-Tam E; Cuckle H
Prenat Diagn; 2015 Jul; 35(7):709-16. PubMed ID: 25846403
[TBL] [Abstract][Full Text] [Related]
12. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
13. Increased time-to-pregnancy and first trimester Down's syndrome screening.
Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
[TBL] [Abstract][Full Text] [Related]
14. Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21.
Wright D; Abele H; Baker A; Kagan KO
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):309-13. PubMed ID: 21400623
[TBL] [Abstract][Full Text] [Related]
15. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
16. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
[TBL] [Abstract][Full Text] [Related]
17. The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A MoM in normal and trisomy 21 pregnancies.
Cowans NJ; Stamatopoulou A; Maiz N; Spencer K; Nicolaides KH
Prenat Diagn; 2009 Jun; 29(6):578-81. PubMed ID: 19288535
[TBL] [Abstract][Full Text] [Related]
18. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
20. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
Spencer K; Bindra R; Cacho AM; Nicolaides KH
Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
